Personalized ovarian cancer vaccines spark immunity in phase 1 trial
Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these neoantigens and prevent cancer from returning after treatment.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Mindfulness-based behavioral therapy changes brain responses to reduce opioid cravings
United Kingdom
-
Aging people with autism more likely to have Parkinson's disease symptoms
United Kingdom
-
Diabetes medication may lower heart attack and stroke risk by curbing platelet overactivation
United Kingdom
-
Michigan Medicine study reveals how diabetes drug reduces stroke risk
United Kingdom
-
Fed holds interest rates steady even as inflation remains stubborn
United States
-
Targeted drug combination extends survival in advanced kidney cancer
United Kingdom
-
Snake-inspired soft robot could help doctors diagnose and treat small intestine disorders
United Kingdom
-
Health coverage more strongly associated with income than world region
United Kingdom